Roofing Roundtable: What’s Hot and What’s Not in Commercial Roofing

 

On this episode of the MarketScale Building Management Podcast, host Daniel Litwin, the Voice of B2B, was joined by Todd Jenkins, President of Jenkins Roofing, Jennifer Long, National Manager for Commercial Contractor Programs at GAF, and Jo Ann Moreno, Senior Commercial Territory Manager at GAF for a roundtable podcast discussion on the current state of commercial roofing.

The discussion began with thoughts on what’s hot, and what’s not in today’s commercial roofing industry. Jenkins said a lot of building owners are looking for certified inspections from certified roofers. And what wasn’t hot? Roofs that are not being looked after or maintained for months and years at a time.

Long and Moreno agreed, with Moreno adding, the building managers are becoming more educated on roofing maintenance and what they want out of a maintenance contract. Jenkins noted, managers were becoming more specific in the roofing materials they were looking for.

“Everyone wants a No Dollar Limit (NDL) Warranty, right now,” Moreno said.

An NDL is the protection from the manufacturer to the owner. Long told the panel that often times roofs are replaced too frequently, when maintenance and repairs were all that was needed. Long mentioned there was an opportunity for contractors to differentiate themselves from those who are quick to replace than to repair.

The podcast roundtable went on to discuss common roofing misconceptions, like having an NDL warranty means the roof is maintenance free for the next 20 years; the discussion further stressed the need to proactive maintain one’s roof to ensure longevity.

Listen to this roofing roundtable for insights into how different regions should prepare their roofs uniquely for weather, how solar adds new layers of inspection education to the industry, and where data from AI might take roofing inspections in the future.

For the latest news, videos, and podcasts in the Building Management Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

AI in marketing
From Queries to Conversations with AI in Marketing Analytics
April 21, 2025

In this episode of the SparkCast, Aby Varma—founder of Spark Novus, a firm that helps marketing leaders adopt AI responsibly and strategically—sits down with Daniel Kravtsov, CEO and Co-Founder of Improvado. Daniel shares his unique journey from Russia to founding a cutting-edge martech company in the Bay Area. Together, they explore how AI agents…

Read More
ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More